Preparing the injection. The outlook for fighting malaria looks optimistic with the release of vaccines like the R21/Matrix M. Copyright: Tom Wilkinson/University of Oxford
Listen on Apple PodcastsListen on SpotifyListen on Google PodcastsListen on StitcherListen on OvercastListen on Amazon MusicListen on CastboxListen on Podcast AddictListen on Pocket CastsListen on iHeartRadioListen on PandoraRSS Feed
Season 4, Episode 9
With the rollout of two new malaria vaccines on the horizon in Africa, the outlook for fighting the disease looks optimistic. But is it enough?
In this episode of our Africa Science Focus Science Explained series, Michael Charles, head of the RBM Partnership to End Malaria, tells us why he believes Africa must lead the drive to end the disease. Charles hails the “groundbreaking” latest WHO-recommended malaria vaccine, R21/Matrix M, but stresses the need to keep up other malaria control measures too.
We also hear from Chika Offor, CEO of the Vaccine Network for Disease Control, who says people in the region must see the value of the vaccine if the rollout campaign is to be successful.
Advertisement
Do you have any comments, questions or feedback about our podcast episodes? Let us know at [email protected]
This piece was produced by SciDev.Net’s Sub-Saharan Africa English desk.
Advertisement
Add a comment
